Vericel Corp. (VCEL)
57.86
+0.44
(+0.77%)
USD |
NASDAQ |
Nov 13, 10:51
Vericel Net Income (Annual) : 16.52M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 16.52M |
| December 31, 2024 | 10.36M |
| December 31, 2023 | -3.182M |
| December 31, 2022 | -16.71M |
| December 31, 2021 | -7.471M |
| December 31, 2020 | 2.864M |
| December 31, 2019 | -9.665M |
| December 31, 2018 | -8.137M |
| December 31, 2017 | -17.29M |
| December 31, 2016 | -19.57M |
| December 31, 2015 | -16.34M |
| December 31, 2014 | -19.92M |
| December 31, 2013 | -20.97M |
| December 31, 2012 | -29.47M |
| December 31, 2011 | -19.67M |
| Date | Value |
|---|---|
| December 31, 2010 | -38.18M |
| June 30, 2009 | -15.95M |
| June 30, 2008 | -20.13M |
| June 30, 2007 | -17.59M |
| June 30, 2006 | -16.48M |
| June 30, 2005 | -11.81M |
| June 30, 2004 | -10.49M |
| June 30, 2003 | -9.579M |
| June 30, 2002 | -7.939M |
| June 30, 2001 | -5.926M |
| June 30, 2000 | -9.39M |
| June 30, 1999 | -11.03M |
| June 30, 1998 | -17.23M |
| June 30, 1997 | -14.29M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |
| Biogen, Inc. | 1.293B |